Re: RVNC/MYL Botox-biosimilar deal (update) From #msg-138939208 (posted 3/1/18): My reservation is that RVNC isn't getting enough early (i.e. up-front + clinical-milestones) cash for a deal of this nature. I'm no longer neutral on this deal. The new inference that RVNC has the Botox cell line (#msg-139376820, bottom) tips my view in favor of bullishness.